Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
7.69
-0.02 (-0.26%)
At close: Feb 10, 2026, 4:00 PM EST
7.69
0.00 (0.00%)
After-hours: Feb 10, 2026, 4:04 PM EST
Instil Bio Market Cap
Instil Bio has a market cap or net worth of $52.15 million as of February 10, 2026. Its market cap has decreased by -65.90% in one year.
Market Cap
52.15M
Enterprise Value
58.22M
1-Year Change
-65.90%
Ranking
Category
Stock Price
$7.69
Market Cap Chart
Since the IPO on March 19, 2021, Instil Bio's market cap has decreased from $2.52B to $52.15M, a decrease of -97.93%. That is a compound annual growth rate of -54.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 52.29M | -29.91% |
| Dec 31, 2025 | 74.60M | -40.12% |
| Dec 31, 2024 | 124.58M | 151.37% |
| Dec 29, 2023 | 49.56M | -39.38% |
| Dec 30, 2022 | 81.76M | -96.29% |
| Dec 31, 2021 | 2.21B | -12.33% |
| Mar 19, 2021 | 2.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TScan Therapeutics | 55.77M |
| Radiopharm Theranostics | 55.26M |
| Cingulate | 54.48M |
| Tevogen Bio Holdings | 52.40M |
| Nutriband | 51.78M |
| MiNK Therapeutics | 51.68M |
| Q32 Bio | 51.43M |
| Acrivon Therapeutics | 51.12M |